Trials / Recruiting
RecruitingNCT07199530
Association Between Plasma D Dimer in Adult CAP and Severity of Inflammatory Response and Survival
Association Between Elevated Plasma D-dimer in Adult Community-acquired Pneumonia Patients and Severity of Inflammatory Response and Survival
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study aims to investigate the association between elevated plasma D-dimer levels and the inflammatory response, as well as its impact on survival in adult patients with community-acquired pneumonia. the study participants will be subjected to sampling for D-dimer and calculation of CURB-65 score. this aims to find the relation between them
Detailed description
Community-acquired pneumonia (CAP) is a common and potentially life-threatening infection that affects millions of individuals worldwide each year. D-dimer is a fibrin degradation product that is elevated in many conditions associated with inflammation and coagulation activation, including pneumonia. This is an observational study including a minimum of 50 patients with CAP Patients who will be admitted to the Chest department, or coming to the outpatient clinic at Ain-Shams University Hospitals with CAP, and have the following inclusions: 1. age ≥18 years 2. diagnosis of CAP based on clinical symptoms, laboratory findings, and radiological evidence. 3. Did not have any clinical or radiological signs suggesting COVID-19 pneumonia Exclusion criteria Patients with a history of coagulation disorders, cancer, or other chronic diseases, or refusal to participate. All patients will be subjected to the following: - 1. Full medical history, demographics 2. Thorough clinical examination. 3. laboratory values (including white blood cell count, CRP, and D-dimer), With pre and post sample known precautions (8). 4. Radiological findings (CXR). 5. Severity of illness (based on the CURB-65 score).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Product | blood sample for D-dimer |
Timeline
- Start date
- 2025-03-23
- Primary completion
- 2026-03-01
- Completion
- 2026-04-01
- First posted
- 2025-09-30
- Last updated
- 2026-02-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07199530. Inclusion in this directory is not an endorsement.